NCT02555839 Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice Status COMPLETED Phase N/A
NCT02553460 Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02551133 Comparison of Dexamethasone Doses on Persistent Postmastectomy Pain Status UNKNOWN Phase PHASE4
NCT02550119 Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy Status TERMINATED Phase NA
NCT02548962 Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT02547662 Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia Status COMPLETED Phase PHASE2
NCT02547623 Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery Status COMPLETED Phase PHASE3
NCT02545907 A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis Status COMPLETED Phase PHASE1/PHASE2
NCT02544425 VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT) Status UNKNOWN Phase PHASE2
NCT02544308 Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02542657 Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02542111 A Study of Bortezomib Plus GDP in the Treatment of Refractory and Relapsed Non-GCB DLBCL Status UNKNOWN Phase PHASE2
NCT02540720 The Research of Standard Diagnosis and Treatment for Severe HSP in Children Status UNKNOWN Phase PHASE2
NCT02535806 Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults Status TERMINATED Phase PHASE2
NCT02532192 A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma Status WITHDRAWN Phase PHASE1
NCT02526199 Protracted Mixture of Local Anesthetics for Major Foot and Ankle Surgery Status COMPLETED Phase PHASE4
NCT02525848 Aprepitant Versus Gabapentin Prophylaxis for Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgeries Status COMPLETED Phase PHASE2/PHASE3
NCT02523976 Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT02520115 Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer Status COMPLETED Phase PHASE1
NCT02519842 Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondansetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044) Status TERMINATED Phase PHASE3